Search research articles
Contact Us
Filters
Showing results (401-410 of 441) with videos related to
Page
of 45
Sort By:
JAMA
|
May 6, 2015
Fixed-dose combination therapy with daclatasvir, asunaprevir, and beclabuvir for noncirrhotic patients with HCV genotype 1 infection
Fred Poordad, William Sievert, Lindsay Mollison, et al.
JHEP Reports : Innovation in Hepatology
|
November 9, 2020
Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area
Giuliana Amaddeo, Raffaele Brustia, Manon Allaire, et al.
The Lancet. Infectious Diseases
|
March 17, 2015
Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS)
Marc Bourlière, Jean-Pierre Bronowicki, Victor de Ledinghen, et al.
Journal of Hepatology
|
October 27, 2016
Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication
Adriaan J van der Meer, Jordan J Feld, Harald Hofer, et al.
Annals of Hepatology
|
July 19, 2023
Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area: What's new 12 months later?
Raffaele Brustia, Mohamed Bouattour, Manon Allaire, et al.
BMC Infectious Diseases
|
April 4, 2019
Safety and efficacy of the combination simeprevir-sofosbuvir in HCV genotype 1- and 4-mono-infected patients from the French ANRS CO22 hepather cohort
Anne Laurain, Sophie Metivier, Georges Haour, et al.
Hepatology (Baltimore, Md.)
|
April 4, 2017
Assessment of biopsy-proven liver fibrosis by two-dimensional shear wave elastography: An individual patient data-based meta-analysis
Eva Herrmann, Victor de Lédinghen, Christophe Cassinotto, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
June 10, 2011
A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel
Markus Cornberg, Homie A Razavi, Alfredo Alberti, et al.
Oncotarget
|
October 4, 2017
<i>BRIP1</i> coding variants are associated with a high risk of hepatocellular carcinoma occurrence in patients with HCV- or HBV-related liver disease
Abderrahim Oussalah, Patrice Hodonou Avogbe, Erwan Guyot, et al.
Journal of Hepatology
|
September 14, 2016
Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients
Stanislas Pol, Marc Bourliere, Sandy Lucier, et al.
Page
of 45
Search research articles
Search
Showing results (401-410 of 441) with videos related to
Sort By:
Page
of 45
JAMA
|
May 6, 2015
Fixed-dose combination therapy with daclatasvir, asunaprevir, and beclabuvir for noncirrhotic patients with HCV genotype 1 infection
Fred Poordad, William Sievert, Lindsay Mollison, et al.
JHEP Reports : Innovation in Hepatology
|
November 9, 2020
Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area
Giuliana Amaddeo, Raffaele Brustia, Manon Allaire, et al.
The Lancet. Infectious Diseases
|
March 17, 2015
Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS)
Marc Bourlière, Jean-Pierre Bronowicki, Victor de Ledinghen, et al.
Journal of Hepatology
|
October 27, 2016
Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication
Adriaan J van der Meer, Jordan J Feld, Harald Hofer, et al.
Annals of Hepatology
|
July 19, 2023
Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area: What's new 12 months later?
Raffaele Brustia, Mohamed Bouattour, Manon Allaire, et al.
BMC Infectious Diseases
|
April 4, 2019
Safety and efficacy of the combination simeprevir-sofosbuvir in HCV genotype 1- and 4-mono-infected patients from the French ANRS CO22 hepather cohort
Anne Laurain, Sophie Metivier, Georges Haour, et al.
Hepatology (Baltimore, Md.)
|
April 4, 2017
Assessment of biopsy-proven liver fibrosis by two-dimensional shear wave elastography: An individual patient data-based meta-analysis
Eva Herrmann, Victor de Lédinghen, Christophe Cassinotto, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
June 10, 2011
A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel
Markus Cornberg, Homie A Razavi, Alfredo Alberti, et al.
Oncotarget
|
October 4, 2017
<i>BRIP1</i> coding variants are associated with a high risk of hepatocellular carcinoma occurrence in patients with HCV- or HBV-related liver disease
Abderrahim Oussalah, Patrice Hodonou Avogbe, Erwan Guyot, et al.
Journal of Hepatology
|
September 14, 2016
Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients
Stanislas Pol, Marc Bourliere, Sandy Lucier, et al.
Page
of 45